Study | Temperature | Side effects | Comfort |
---|---|---|---|
Lal et al9 | Insufficient data | Slightly raised SGPT, SGOT, urea and creatinine in mixed group. No clinical significance | No data |
Erlewyn-Lajeunesse et al14 | Mean fall over 1 h °C (t) No clinically or statistically significant difference | No data | No data |
P 0.95, I 0.92, PI 1.22 | |||
Nabulsi et al13 | % Afebrile at 6–8 h (r) greater in mixed group | No serious adverse reactions. No sign of GI, hepatic, renal toxicity | No data |
6 h: I 57.6, PI 83.3, p=0.018 | |||
7 h: I 45.2, PI 86.1, p<0.001 | |||
8 h: I 35.5, PI 80.6, p<0.001 | |||
Max temperature decline no difference | |||
Sarrell et al11 | Mean max temperature on days 1–3 °C (r) lowest in mixed group, highest in paracetamol | No differences in renal and liver values and no abnormalities at 14 days | NCCPC score and repeat dosages on days 1–3 lower in mixed group, highest in paracetamol group |
1 day: P 40.6, I 40.6, PI 39.6 p<0.001 | |||
2 day: P 39.7, I 39.7, PI 38.8 p<0.001 | |||
3 day: P 39.3, I 39.6, PI 38.5 p<0.001 | |||
Hay et al10 | Minutes without feverfirst 4 h (a): greatest in mixed group, shortest in paracetamol group | Diarrhoea, vomiting, rash, cough, cold to touch, admitted to hospital no differences and none considered to be related to study | No discomfort at 48 h, pairwise comparisons no difference |
P 116.2, I 156, PI 171.1 | |||
Pairwise comparisonmixed vs paracetamol p<0.001, ibuprofen vs paracetamol p=0.001 | |||
First 24 h: same pattern | |||
P 940.3, PI 1055.2, PI 1217.4 | |||
Kramer et al12 | Mean temperature at 3–6 h °C (o/r)no difference at 3 or 6 h, at 4 and 5 h lower in mixed group | No side effects prevented administration and did not differ between groups | Repeat dosages needed at 3 and 4 h no difference |
4 h: P 38, PI 37.4, p=0.05 | |||
5 h: P 37.9, PI 37.1, p=0.003 | |||
Paul et al15 | Mean temperature at 1–6 h °C (ta) no difference at 1–3 h, at 4–6 h lower in mixed (PI) and alternating (IP) than ibuprofen (note order of groups) | Did not evaluate effect of multiple doses or adverse events that could occur from this | No data |
4 h: IP 36.9, I 37.5, PI 36.9, p=0.002 | |||
5 h: IP 36.8, I 38, PI 36.9, p<0.001 | |||
6 h: IP 36.9, I 38.5, PI 37.2, p<0.001 |
a, axilla; I, ibuprofen; GI, gastrointestinal; NCCPC, non-communicating children's pain checklist; o, oral; P, paracetamol; PI/IP paracetamol and ibuprofen; r, rectal; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; t, tympanic; ta, temporal artery.